A detailed history of Ubs Group Ag transactions in Astrazeneca PLC stock. As of the latest transaction made, Ubs Group Ag holds 1,832,320 shares of AZN stock, worth $139 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,832,320
Previous 13,400 13574.03%
Holding current value
$139 Million
Previous $907,000 15655.46%
% of portfolio
0.04%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $4.28 Million - $5.18 Million
-64,050 Reduced 3.38%
1,832,320 $143 Million
Q1 2024

May 13, 2024

SELL
$61.03 - $69.57 $29.4 Million - $33.5 Million
-481,973 Reduced 20.27%
1,896,370 $128 Million
Q4 2023

Feb 09, 2024

BUY
$61.89 - $69.28 $26.1 Million - $29.2 Million
421,076 Added 21.51%
2,378,343 $160 Million
Q3 2023

Nov 09, 2023

BUY
$64.85 - $71.7 $11.1 Million - $12.3 Million
171,480 Added 9.6%
1,957,267 $133 Million
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $20.4 Million - $22.1 Million
291,457 Added 19.5%
1,785,787 $128 Million
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $3.7 Million - $4.19 Million
58,518 Added 4.08%
1,494,330 $104 Million
Q4 2022

Feb 08, 2023

BUY
$54.21 - $70.44 $16.2 Million - $21.1 Million
299,574 Added 26.37%
1,435,812 $97.3 Million
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $7.65 Million - $19.6 Million
144,325 Added 14.55%
1,136,238 $62.3 Million
Q2 2022

Aug 10, 2022

SELL
$59.26 - $71.14 $9.54 Million - $11.5 Million
-160,959 Reduced 13.96%
991,913 $65.5 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $9.79 Million - $11.8 Million
175,698 Added 17.98%
1,152,872 $76.5 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $827,100 - $977,301
-15,311 Reduced 1.54%
977,174 $56.9 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $5.06 Million - $5.54 Million
91,142 Added 10.11%
992,485 $59.6 Million
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $1.67 Million - $2.07 Million
34,432 Added 3.97%
901,343 $54 Million
Q1 2021

May 12, 2021

SELL
$47.16 - $54.44 $1.01 Million - $1.17 Million
-21,466 Reduced 2.42%
866,911 $43.1 Million
Q4 2020

Feb 11, 2021

BUY
$48.52 - $58.02 $2.69 Million - $3.22 Million
55,457 Added 6.66%
888,377 $44.4 Million
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $937,322 - $1.08 Million
-17,662 Reduced 2.08%
832,920 $45.6 Million
Q2 2020

Jul 31, 2020

SELL
$43.1 - $55.31 $2.88 Million - $3.7 Million
-66,932 Reduced 7.29%
850,582 $45 Million
Q1 2020

May 01, 2020

SELL
$37.79 - $51.33 $11.3 Million - $15.3 Million
-297,932 Reduced 24.51%
917,514 $41 Million
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $2.13 Million - $2.54 Million
-50,255 Reduced 3.97%
1,215,446 $60.6 Million
Q3 2019

Nov 14, 2019

SELL
$40.12 - $45.47 $4.66 Million - $5.28 Million
-116,149 Reduced 8.41%
1,265,701 $56.4 Million
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $20.4 Million - $22.8 Million
-545,990 Reduced 28.32%
1,381,850 $57 Million
Q1 2019

May 14, 2019

SELL
$35.49 - $43.02 $6.99 Million - $8.48 Million
-197,040 Reduced 9.27%
1,927,840 $77.9 Million
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $9.35 Million - $10.5 Million
-253,790 Reduced 10.67%
2,124,880 $80.7 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $11.2 Million - $12.8 Million
-321,560 Reduced 11.91%
2,378,670 $94.1 Million
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $4.83 Million - $5.17 Million
-139,676 Reduced 4.92%
2,700,230 $94.8 Million
Q1 2018

May 15, 2018

SELL
$32.97 - $36.63 $2.02 Million - $2.25 Million
-61,331 Reduced 2.11%
2,839,906 $99.3 Million
Q4 2017

Feb 14, 2018

SELL
$32.09 - $34.78 $8.51 Million - $9.22 Million
-265,221 Reduced 8.38%
2,901,237 $101 Million
Q3 2017

Nov 14, 2017

SELL
$28.96 - $34.0 $3.05 Million - $3.58 Million
-105,432 Reduced 3.22%
3,166,458 $107 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-352,891 Reduced 9.74%
3,271,890 $112 Million
Q1 2017

Nov 14, 2017

BUY
N/A
3,624,781
3,624,781 $113 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $236B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.